Drug Trial Radar · NCT07231679
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
94
Planned (sponsor's estimate)
Start
Oct 30, 2025
Primary completion
Dec 2026
Study completion Apr 2027
Sponsor
- Lead sponsor
- Ingenia Therapeutics INCIndustry
- Sponsor type
- Industry
- First posted
- Nov 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to observe the safety of IGT-303 in healthy volunteers and participants with Chronic Kidney Disease. The main question it aims to answer is: Is IGT-303 safe as a single dose or multiple dose regimen when applied under the skin (subcutaneously (SC)) or to a vein (intravenously (IV)). Researchers will compare IGT-303 against a placebo to see if IGT-303 is safe for use. Participants will be assigned to either IGT-303 or placebo and assessed for safety and tolerability for the duration of the study.
Conditions
- Healthy Volunteers
- Chronic Kidney Disease
Interventions
IGT-303Drug
IGT-303 administered via IV or SC
PlaceboDrug
Saline
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse events (AEs), serious adverse events (SAEs), and treatment-emergent adverse events (TEAEs)Time frame: From Screening to Day 84.
Locations
13 sites in 4 countries. Site status is shown where the registry gives one.
Balboa Nephrology - Chula Vista
Chula Vista, California · Not yet recruiting
Clinical Research of Central Florida
Lakeland, Florida · Not yet recruiting
Piedmont HealthCare
Statesville, North Carolina · Not yet recruiting
Wilmington Health
Wilmington, North Carolina · Not yet recruiting
Nucleus Network
Herston, Brisbane, Australia · Recruiting
Renal Research
Gosford, New South Wales, Australia · Recruiting
Concord Repatriation General Hospital
Sydney, New South Wales, Australia · Recruiting
University of the Sunshine Coast Clinical Trials-Southbank
Morayfield, Queensland, Australia · Recruiting
University of the Sunshine Coast-Morayfield
Morayfield, Queensland, Australia · Recruiting
Sunshine Hospital
Saint Albans, Victoria, Australia · Recruiting
Pacific Clinical Research Network
Takapuna, Auckland, New Zealand · Recruiting
Momentum Clinical Research
Waikanae Beach, Kapiti Coast, New Zealand · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.